Results 171 to 180 of about 22,517 (214)
Some of the next articles are maybe not open access.
Neonatal Network, 2006
A CHYLOTHORAX IS CHARACTERIZED BY AN ACCUMULATION OF pleural fluid having a turbid or milky white appearance due to a high lipid and triglyceride content. This continuously draining fluid, called chyle, contains lymphocytes, proteins, and immunoglobulins.
Gregory V, Stajich, Laurel, Ashworth
openaire +2 more sources
A CHYLOTHORAX IS CHARACTERIZED BY AN ACCUMULATION OF pleural fluid having a turbid or milky white appearance due to a high lipid and triglyceride content. This continuously draining fluid, called chyle, contains lymphocytes, proteins, and immunoglobulins.
Gregory V, Stajich, Laurel, Ashworth
openaire +2 more sources
Expert Review of Endocrinology & Metabolism, 2007
Octreotide has dramatically changed the results of medical treatment of acromegaly. It is the reference drug for the pharmacological treatment of acromegaly, owing to its impressive efficacy in suppressing growth hormome secretion, and excellent compliance.
R. Cozzi, R. Attanasio
openaire +3 more sources
Octreotide has dramatically changed the results of medical treatment of acromegaly. It is the reference drug for the pharmacological treatment of acromegaly, owing to its impressive efficacy in suppressing growth hormome secretion, and excellent compliance.
R. Cozzi, R. Attanasio
openaire +3 more sources
Supportive Care in Cancer, 1994 Dear Editor, I read with interest the short communication of Stiefel and Morant on the effects of vapreotide in the management of intestinal obstruction [6]. I would like to add some comments. Drug treatment is widely recognized for the management of bowel obstruction in patients with advanced cancer [5].
Rudolf Morant, S. Mercadante
openaire +1 more source
Octreotide‐Induced Bradycardia [PDF]
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1998 Because of deleterious hemodynamic effects of octreotide in a nonacromegalic patient with a pancreatic fistula, we conducted a MEDLINE search of English‐language journal articles to extract information on this complication of octreotide or somatostatin therapy. Few data are available regarding patients with disease states other than acromegaly.
Annie M. Herrington +2 more
openaire +2 more sources
Octreotide‐Induced Hyperkalemia
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1994A 68‐year‐old woman was admitted with numerous injuries after being hit by an automobile. On day 16 of hospitalization octreotide was started for treatment of a pancreatic fistula, and within 2 days the patient's serum potassium increased. By the third and fourth days of octreotide therapy the level had increased to the point at which it required ...
Richard J. Kuwik +4 more
openaire +3 more sources
Octreotide in Pediatric Patients
Journal of Pediatric Gastroenterology and Nutrition, 2002INTRODUCTIONSomatostatin, a naturally occurring tetradecapeptide, and its synthetic analogue octreotide, have been used to treat secretory diarrhea, various pancreatic disorders, and bleeding from esophageal varices.
John C. Bucuvalas +3 more
openaire +3 more sources
Thrombocytopenia Associated with Octreotide
The American Journal of the Medical Sciences, 2000A 42-year-old woman with a history of hepatitis C-induced cirrhosis, gastrointestinal bleeding, and alcohol abuse presented to the hospital with hematemesis and melena. Based on our previous experience, octreotide (Sandostatin) therapy was started at 50 mg/hr and continued for 5 days.
Jaquelyn Fleckenstein +2 more
openaire +3 more sources
BMJ Supportive & Palliative Care, 2020
Octreotide is a synthetic somatostatin analogue with several palliative care indications, including management of ascites, bowel obstruction, diarrhoea, fistulae and tumour secretions. We report a case in which parotid swelling occurred after octreotide, suggesting it may have been a causative factor in a salivary duct calculus.
openaire +3 more sources
Octreotide is a synthetic somatostatin analogue with several palliative care indications, including management of ascites, bowel obstruction, diarrhoea, fistulae and tumour secretions. We report a case in which parotid swelling occurred after octreotide, suggesting it may have been a causative factor in a salivary duct calculus.
openaire +3 more sources
Octreotide hardens the pancreas
Langenbeck's Archives of Surgery, 2006Leakage from pancreaticojejunostomy and development of pancreatic fistulas are the major postoperative complications in patients undergoing duodenopancreatectomy. The risk of developing these complications is higher when surgery is performed on a soft pancreas.
Ernst Klar +4 more
openaire +3 more sources
Somatostatin and octreotide in gastroenterology
Alimentary Pharmacology & Therapeutics, 1991SUMMARYSomatostatin and octreotide have a definitive role in the management of symptomatic gut neuroendocrine tumours, particularly VIPomas and carcinoid. They probably also have a role in variceal bleeding, but this needs further confirmatory randomized trials.
P. A. McCORMICK, A.K. Burroughs
openaire +2 more sources